Episódios
-
Professor Marie-José Tassignon shares her insight on pediatric cataract surgery, she speaks about the importance of anatomical changes in the anterior interface of the eye.
Video: https://medicaldigest.org/scientific-contents/standalonecontent:importance-anterior-interface-eye-surgery
-
Professor Philippe Moulin shares his insights on the highlights of the EAS 2024 and how to treat atherosclerosis.
The second part of our two-part interview
- New insights in the genetics of dyslipidaemia
- New data from the registries: INTERSPIRE
- Anitschkow Prize & Lecture 2024: Recipient: Bart Staels
- ESC/EAS Joint Symposium on risk scores, modifiers and comorbidities
Video: https://medicaldigest.org/scientific-contents/interview:how-treat-atherosclerosis-highlights-eas-2024-part-ii
To watch the first part of the interview, click here: https://medicaldigest.org/scientific-contents/interview:how-treat-atherosclerosis-highlights-eas-2024-part-i
-
Estão a faltar episódios?
-
Professor Philippe Moulin shares his insights on the highlights of the EAS 2024 and how to treat atherosclerosis.
The first part of our two-part interview covered the following topics:
- Combating the triple threat: Cardiovascular disease, Diabetes mellitus, Chronic kidney disease.
- Real world solutions for LDL-C management.
- Can therapies alter the course of atherosclerotic cardiovascular disease?
Shall we treat inflammation in atherosclerosis?
- Role of diet and lifestyle in prevention and treatment of atherosclerosis?
Video: https://medicaldigest.org/scientific-contents/interview:how-treat-atherosclerosis-highlights-eas-2024-part-i
To watch the second part of the interview, click on the link below: https://medicaldigest.org/scientific-contents/interview:how-treat-atherosclerosis-highlights-eas-2024-part-ii
-
Sytske Anne Bergstra at the recent EULAR 2024 chaired a session on the use of glucocorticoids in the therapy of rheumatoid arthritis. What were the key steps in 75 years of glucocorticoid history until they occupied their present therapeutic position?
Video: https://medicaldigest.org/scientific-contents/interview:75th-anniversary-glucocorticoids-what-have-we-learnt
-
Professor Dennis McGonagle explains the results of an EULAR 2024 late breaking abstract, the PRO-SPIRIT study, early (3-month) and maintained (12-month) comparative effectiveness of 5 different classes of advanced therapies in a large multinational cohort of real-world PsA patients.
Video: https://medicaldigest.org/scientific-contents/interview:early-and-maintained-comparative-effectiveness-5-different-classes-advanced-therapies-large-multinational-cohort-real-world-psa-patients
-
Professor Gerd Horneff explains the results of a late breaking abstract from EULAR 2024, effectiveness of canakinumab for first line steroid free treatment in systemic onset juvenile idiopathic arthritis/ juvenile Still’s disease.
Video: https://medicaldigest.org/scientific-contents/interview:what-new-osteoporosis-rheumatology
-
Professor David Isenberg shares an update on novel treatments for lupus and their clinical applications.
Video: https://medicaldigest.org/scientific-contents/interview:lupus-whats-horizon
-
Professor Denis Poddubnyy shared the results of AScalate trial, Secukinumab versus standard-of-care in axial spondyloarthritis, a randomized controlled open-label trial for treat-to-target outcomes.
Video: https://medicaldigest.org/scientific-contents/interview:secukinumab-versus-standard-care-axial-spondyloarthritis
-
Professor Roland Chapurlat shares his experiences on high risk osteoporosis combination terapies, on OP and CKD, as well on pregnancy and OP.
Video: https://medicaldigest.org/scientific-contents/interview:difficult-questions-osteoporosis
-
Professor Annette H. M. van der Helm van Mil share her thoughts about EULAR Recommendations on risk stratification in patients with arthralgia suspicious for progression to Rheumatoid Arthritis.
Video: https://medicaldigest.org/scientific-contents/interview:update-eularacr-project-risk-stratification-patients-arthralgia-suspicious-progression-ra
-
Professor Rene Westhovens chaired an interesting session during EULAR 2024, where participants learned to recognise the range of pain and fatigue manifestations and impact in Rheumatic and Musculoskeletal Diseases and heared about options for managing different pain mechanisms in RMDs. State of the art and risks of opioid use are discussed and the role of self-management approaches to manage pain and fatigue and reduce opioid use are presented.
Video: https://medicaldigest.org/scientific-contents/interview:fatigue-pain-and-opioids-rheumatological-diseases
-
Professor Michael Nurmohamed shares his experiences on cardiovascular comorbidities of Rheumatic and Musculoskeletal Diseases and their management, as well as new findings such as the results of the ORAL Surveillance study.
Video: https://medicaldigest.org/scientific-contents/interview:cardiovascular-risk-rheumatic-musculoskeletal-disease
-
Professor Francisca Sivera chaired an informative session during EULAR 2024, on the long-term consequences of asymptomatic urate deposition in the joint, critically appraise the evidence regarding urate-lowering therapy for renal disease and discern the extent to which hyperuricemia contributes to cardiovascular disease.
Video: https://medicaldigest.org/scientific-contents/interview:asymptomatic-hyperuricemia-innocent-bystander-or-menacing-foe
-
Professor Raphael Micheroli chaired an exciting session during EULAR 2024, an update on the results of RA prevention trials to date, describe the lessons learnt from these RCTs.
Video: https://medicaldigest.org/scientific-contents/interview:rheumatoid-arthritis-prevention-what-have-we-learnt-and-where-do-we-go-next
- Mostrar mais
